Joana C Silva
Overview
Explore the profile of Joana C Silva including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
4122
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Scalsky R, Dwivedi A, Stabler T, Mbambo G, Ouattara A, Lyke K, et al.
Vaccine
. 2025 Feb;
50:126783.
PMID: 39923546
Discovery of new protective malaria antigens will enable the development of novel vaccine formulations with potentially higher efficacy. While several high-throughput experimental approaches enable the identification of novel immunogens, none...
2.
Lawton J, Zhou A, Stucke E, Takala-Harrison S, Silva J, Travassos M
Infect Genet Evol
. 2025 Feb;
129:105725.
PMID: 39920908
The repetitive interspersed family (rif) and subtelomeric variable open reading frames (stevor) are highly diverse multi-gene families in the malaria parasite Plasmodium falciparum. Embedded on the surface of infected erythrocytes,...
3.
Daubenberger C, Silva J
Lancet
. 2024 Apr;
403(10437):1607-1609.
PMID: 38583452
No abstract available.
4.
Guo B, Borda V, Laboulaye R, Spring M, Wojnarski M, Vesely B, et al.
Nat Commun
. 2024 Mar;
15(1):2499.
PMID: 38509066
Malaria genomic surveillance often estimates parasite genetic relatedness using metrics such as Identity-By-Decent (IBD), yet strong positive selection stemming from antimalarial drug resistance or other interventions may bias IBD-based estimates....
5.
Potter G, Callier V, Shrestha B, Joshi S, Dwivedi A, Silva J, et al.
Malar J
. 2023 Dec;
22(1):383.
PMID: 38115002
Background: Early phase malaria vaccine field trials typically measure malaria infection by PCR or thick blood smear microscopy performed on serially sampled blood. Vaccine efficacy (VE) is the proportion reduction...
6.
Thomson-Luque R, Stabler T, Furle K, Silva J, Daubenberger C
Expert Rev Vaccines
. 2023 Dec;
23(1):160-173.
PMID: 38100310
Introduction: Malaria represents a public health challenge in tropical and subtropical regions, and currently deployed control strategies are likely insufficient to drive elimination of malaria. Development and improvement of malaria...
7.
Palmateer N, Munro J, Nagaraj S, Crabtree J, Pelle R, Tallon L, et al.
J Mol Evol
. 2023 Nov;
91(6):897-911.
PMID: 38017120
Multigene families often play an important role in host-parasite interactions. One of the largest multigene families in Theileria parva, the causative agent of East Coast fever, is the T. parva...
8.
Potter G, Callier V, Shrestha B, Joshi S, Dwivedi A, Silva J, et al.
Res Sq
. 2023 Oct;
PMID: 37790581
Background: Early phase malaria vaccine field trials typically measure malaria infection by PCR or thick blood smear microscopy performed on serially sampled blood. Vaccine efficacy (VE) is the proportion reduction...
9.
Richie T, Church L, Murshedkar T, Billingsley P, James E, Chen M, et al.
Expert Rev Vaccines
. 2023 Aug;
22(1):964-1007.
PMID: 37571809
Introduction: Malaria, a devastating febrile illness caused by protozoan parasites, sickened 247,000,000 people in 2021 and killed 619,000, mostly children and pregnant women in sub-Saharan Africa. A highly effective vaccine...
10.
Guo B, Borda V, Laboulaye R, Spring M, Wojnarski M, Vesely B, et al.
bioRxiv
. 2023 Jul;
PMID: 37502843
Malaria genomic surveillance often estimates parasite genetic relatedness using metrics such as Identity-By-Decent (IBD). Yet, strong positive selection stemming from antimalarial drug resistance or other interventions may bias IBD-based estimates....